Global Imaging Reach RadMD offers end-to-end imaging services for clinical trials with a global footprint and a network of subspecialty radiologists, enabling sponsors to run multinational studies with standardized imaging. This positions RadMD to win enterprise deals with large pharma and CROs pursuing global trials, particularly in oncology and across diverse therapeutic areas. The breadth of services supports one-stop procurement and consistent data across sites, reducing vendor management overhead for sponsors.

Integrated iCRO Platform RadMD's integrated iCRO portfolio combines site support, image data management, centralized reads, reader training, and regulatory consulting. For sponsors running complex trials, this enables bundled engagements, streamlined vendor management, and faster study timelines, presenting opportunities to upsell multi-study programs and long-term partnerships.

Regulatory Training Edge With reader training and CME-aligned certification and regulatory consulting, RadMD can help sponsors accelerate startup readiness and site qualification. This creates sellable offerings around investigator training packages, site onboarding, and ongoing quality assurance that can be packaged with trial procurement or as value-added services for sponsors aiming to minimize regulatory risk.

EU Expansion Momentum RadMD has demonstrated growth through EU expansion and is now part of Medica Group's portfolio, signaling scale and cross-border collaboration potential. This can open doors with EU and UK sponsors and global CROs seeking a partner with regional reach, regulatory alignment, and shared networks for imaging services.

Tech Enablement RadMD's tech-forward approach with Salesforce, Microsoft 365, and data-focused tools supports CRM-driven targeting and performance analytics. This enables precise account-based selling, scalable onboarding, and measurable ROI demonstrations to sponsors, while offering integration-ready data flows with sponsor CTMS or LIMS platforms for seamless trial operations.